The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2011
DOI: 10.1016/j.ajem.2009.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Case series of 226 γ-hydroxybutyrate–associated deaths: lethal toxicity and trauma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
121
0
4

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 121 publications
(130 citation statements)
references
References 69 publications
5
121
0
4
Order By: Relevance
“…From 30 to 180 min, GHB plasma concentrations ranged from 1020 to 357 g/ml (9.8 -3.4 mM), 793 to 249 g/ml (7.6 -2.4 mM), and 569 to 69 g/ml (5.5-0.6 mM) for the 800, 600, and 400 mg/kg doses, respectively. Post-mortem GHB plasma concentrations were recently reported to be 18 to 4400 mg/l, or 172 M to 42.2 mM (Zvosec et al, 2011), indicating that the GHB doses used here elicit plasma GHB concentrations that are relevant to concentrations of GHB observed in clinical cases. These data, in conjunction with the dose-normalized ECF concentration-time profiles, the partitioning time course of brain ECF to plasma, and estimated K m values from in vitro uptake studies, suggest that the distribution of GHB into the brain is saturated only at very high plasma concentrations such as those seen after toxic doses of GHB [up to 21 mM (Knudsen et al, 2010) or 42 mM (Zvosec et al, 2011)].…”
Section: Brain Uptake Of Ghbmentioning
confidence: 97%
“…From 30 to 180 min, GHB plasma concentrations ranged from 1020 to 357 g/ml (9.8 -3.4 mM), 793 to 249 g/ml (7.6 -2.4 mM), and 569 to 69 g/ml (5.5-0.6 mM) for the 800, 600, and 400 mg/kg doses, respectively. Post-mortem GHB plasma concentrations were recently reported to be 18 to 4400 mg/l, or 172 M to 42.2 mM (Zvosec et al, 2011), indicating that the GHB doses used here elicit plasma GHB concentrations that are relevant to concentrations of GHB observed in clinical cases. These data, in conjunction with the dose-normalized ECF concentration-time profiles, the partitioning time course of brain ECF to plasma, and estimated K m values from in vitro uptake studies, suggest that the distribution of GHB into the brain is saturated only at very high plasma concentrations such as those seen after toxic doses of GHB [up to 21 mM (Knudsen et al, 2010) or 42 mM (Zvosec et al, 2011)].…”
Section: Brain Uptake Of Ghbmentioning
confidence: 97%
“…[18,19] However, there has been little systematic investigation of the incidence of GHB- likely underestimates the number of deaths due to the fact that GHB analysis is not routinely performed in post-mortem investigations in the UK. [19] As reports suggest that the use of GHB and the incidence of chemsex are increasing, and GHB is the drug most linked to acute harm out of those used in Chemsex, we systematically investigated the numbers of GHB-associated deaths from London Coroners' jurisdictions to see whether there was evidence of increased deaths associated with GHB which suggest increased and/or more dangerous use of the drug.…”
Section: Introductionmentioning
confidence: 99%
“…GHB has also recently been recognized as a common drug of abuse. Overdose cases involving GHB and its precursors, 1,4-butanediol and -butyrolactone, have been reported in the United States and other Western countries and have resulted in GHB-induced coma, respiratory depression, and fatality (Caldicott et al, 2004;Zvosec et al, 2010). …”
Section: Introductionmentioning
confidence: 99%